[Post-transfusional non-A non-B hepatitis. Evaluation of SGPT screening in blood donors].
The incidence of non-A, non-B hepatitis is 10% of post-transfusion hepatitis (PTH), and more than 30% of this occurrence could be prevented with SGPT screening. We have been studying from 1984 this surrogate test in order to prevent non-A, non-B post-transfusion hepatitis. Reported data suggest this screening in all blood donors.
Muglia
M
M
Centro Nazionale Trasfusione Sangue, Croce Rossa Italiana, Roma.
Angeloni
U
U
Angeloni
P
P
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D001782:Blood Donors; D001803:Blood Transfusion / Q000592:standards; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis / Q000201:enzymology / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D065227:Transfusion Reaction
D000410:Alanine Transaminase
L'epatite non-A, non-B post trasfusionale. Valutazione dello screening delle SGPT nei donatori di sangue.